1 Market Overview 1.1 Polycythemia Vera Drug Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Polycythemia Vera Drug Revenue by Type: 2017 Versus 2021 Versus 2028 1.2.2 Dasatinib 1.2.3 Idelalisib 1.2.4 Givinostat 1.2.5 M-009 1.2.6 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Polycythemia Vera Drug Revenue by Application: 2017 Versus 2021 Versus 2028 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Polycythemia Vera Drug Market Size & Forecast 1.4.1 Global Polycythemia Vera Drug Sales in Value (2017 & 2021 & 2028) 1.4.2 Global Polycythemia Vera Drug Sales in Volume (2017-2028) 1.4.3 Global Polycythemia Vera Drug Price (2017-2028) 1.5 Global Polycythemia Vera Drug Production Capacity Analysis 1.5.1 Global Polycythemia Vera Drug Total Production Capacity (2017-2028) 1.5.2 Global Polycythemia Vera Drug Production Capacity by Geographic Region 1.6 Market Drivers, Restraints and Trends 1.6.1 Polycythemia Vera Drug Market Drivers 1.6.2 Polycythemia Vera Drug Market Restraints 1.6.3 Polycythemia Vera Drug Trends Analysis 2 Manufacturers Profiles 2.1 ANP Technologies, Inc. 2.1.1 ANP Technologies, Inc. Details 2.1.2 ANP Technologies, Inc. Major Business 2.1.3 ANP Technologies, Inc. Polycythemia Vera Drug Product and Services 2.1.4 ANP Technologies, Inc. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2 Bristol-Myers Squibb Company 2.2.1 Bristol-Myers Squibb Company Details 2.2.2 Bristol-Myers Squibb Company Major Business 2.2.3 Bristol-Myers Squibb Company Polycythemia Vera Drug Product and Services 2.2.4 Bristol-Myers Squibb Company Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3 F. Hoffmann-La Roche Ltd. 2.3.1 F. Hoffmann-La Roche Ltd. Details 2.3.2 F. Hoffmann-La Roche Ltd. Major Business 2.3.3 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Product and Services 2.3.4 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4 Galena Biopharma, Inc. 2.4.1 Galena Biopharma, Inc. Details 2.4.2 Galena Biopharma, Inc. Major Business 2.4.3 Galena Biopharma, Inc. Polycythemia Vera Drug Product and Services 2.4.4 Galena Biopharma, Inc. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5 Gilead Sciences, Inc. 2.5.1 Gilead Sciences, Inc. Details 2.5.2 Gilead Sciences, Inc. Major Business 2.5.3 Gilead Sciences, Inc. Polycythemia Vera Drug Product and Services 2.5.4 Gilead Sciences, Inc. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6 Italfarmaco S.p.A. 2.6.1 Italfarmaco S.p.A. Details 2.6.2 Italfarmaco S.p.A. Major Business 2.6.3 Italfarmaco S.p.A. Polycythemia Vera Drug Product and Services 2.6.4 Italfarmaco S.p.A. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7 Karus Therapeutics Limited 2.7.1 Karus Therapeutics Limited Details 2.7.2 Karus Therapeutics Limited Major Business 2.7.3 Karus Therapeutics Limited Polycythemia Vera Drug Product and Services 2.7.4 Karus Therapeutics Limited Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.8 miRagen Therapeutics, Inc. 2.8.1 miRagen Therapeutics, Inc. Details 2.8.2 miRagen Therapeutics, Inc. Major Business 2.8.3 miRagen Therapeutics, Inc. Polycythemia Vera Drug Product and Services 2.8.4 miRagen Therapeutics, Inc. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.9 Nerviano Medical Sciences S.r.l. 2.9.1 Nerviano Medical Sciences S.r.l. Details 2.9.2 Nerviano Medical Sciences S.r.l. Major Business 2.9.3 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Product and Services 2.9.4 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.10 Novartis AG 2.10.1 Novartis AG Details 2.10.2 Novartis AG Major Business 2.10.3 Novartis AG Polycythemia Vera Drug Product and Services 2.10.4 Novartis AG Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.11 PharmaEssentia Corporation 2.11.1 PharmaEssentia Corporation Details 2.11.2 PharmaEssentia Corporation Major Business 2.11.3 PharmaEssentia Corporation Polycythemia Vera Drug Product and Services 2.11.4 PharmaEssentia Corporation Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.12 Teva Pharmaceutical Industries Ltd. 2.12.1 Teva Pharmaceutical Industries Ltd. Details 2.12.2 Teva Pharmaceutical Industries Ltd. Major Business 2.12.3 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Product and Services 2.12.4 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 3 Polycythemia Vera Drug Breakdown Data by Manufacturer 3.1 Global Polycythemia Vera Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022) 3.2 Global Polycythemia Vera Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) 3.3 Key Manufacturer Market Position in Polycythemia Vera Drug 3.4 Market Concentration Rate 3.4.1 Top 3 Polycythemia Vera Drug Manufacturer Market Share in 2021 3.4.2 Top 6 Polycythemia Vera Drug Manufacturer Market Share in 2021 3.5 Global Polycythemia Vera Drug Production Capacity by Company: 2021 VS 2022 3.6 Manufacturer by Geography: Head Office and Polycythemia Vera Drug Production Site 3.7 New Entrant and Capacity Expansion Plans 3.8 Mergers & Acquisitions 4 Market Analysis by Region 4.1 Global Polycythemia Vera Drug Market Size by Region 4.1.1 Global Polycythemia Vera Drug Sales in Volume by Region (2017-2028) 4.1.2 Global Polycythemia Vera Drug Revenue by Region (2017-2028) 4.2 North America Polycythemia Vera Drug Revenue (2017-2028) 4.3 Europe Polycythemia Vera Drug Revenue (2017-2028) 4.4 Asia-Pacific Polycythemia Vera Drug Revenue (2017-2028) 4.5 South America Polycythemia Vera Drug Revenue (2017-2028) 4.6 Middle East and Africa Polycythemia Vera Drug Revenue (2017-2028) 5 Market Segment by Type 5.1 Global Polycythemia Vera Drug Sales in Volume by Type (2017-2028) 5.2 Global Polycythemia Vera Drug Revenue by Type (2017-2028) 5.3 Global Polycythemia Vera Drug Price by Type (2017-2028) 6 Market Segment by Application 6.1 Global Polycythemia Vera Drug Sales in Volume by Application (2017-2028) 6.2 Global Polycythemia Vera Drug Revenue by Application (2017-2028) 6.3 Global Polycythemia Vera Drug Price by Application (2017-2028) 7 North America by Country, by Type, and by Application 7.1 North America Polycythemia Vera Drug Sales by Type (2017-2028) 7.2 North America Polycythemia Vera Drug Sales by Application (2017-2028) 7.3 North America Polycythemia Vera Drug Market Size by Country 7.3.1 North America Polycythemia Vera Drug Sales in Volume by Country (2017-2028) 7.3.2 North America Polycythemia Vera Drug Revenue by Country (2017-2028) 7.3.3 United States Market Size and Forecast (2017-2028) 7.3.4 Canada Market Size and Forecast (2017-2028) 7.3.5 Mexico Market Size and Forecast (2017-2028) 8 Europe by Country, by Type, and by Application 8.1 Europe Polycythemia Vera Drug Sales by Type (2017-2028) 8.2 Europe Polycythemia Vera Drug Sales by Application (2017-2028) 8.3 Europe Polycythemia Vera Drug Market Size by Country 8.3.1 Europe Polycythemia Vera Drug Sales in Volume by Country (2017-2028) 8.3.2 Europe Polycythemia Vera Drug Revenue by Country (2017-2028) 8.3.3 Germany Market Size and Forecast (2017-2028) 8.3.4 France Market Size and Forecast (2017-2028) 8.3.5 United Kingdom Market Size and Forecast (2017-2028) 8.3.6 Russia Market Size and Forecast (2017-2028) 8.3.7 Italy Market Size and Forecast (2017-2028) 9 Asia-Pacific by Region, by Type, and by Application 9.1 Asia-Pacific Polycythemia Vera Drug Sales by Type (2017-2028) 9.2 Asia-Pacific Polycythemia Vera Drug Sales by Application (2017-2028) 9.3 Asia-Pacific Polycythemia Vera Drug Market Size by Region 9.3.1 Asia-Pacific Polycythemia Vera Drug Sales in Volume by Region (2017-2028) 9.3.2 Asia-Pacific Polycythemia Vera Drug Revenue by Region (2017-2028) 9.3.3 China Market Size and Forecast (2017-2028) 9.3.4 Japan Market Size and Forecast (2017-2028) 9.3.5 Korea Market Size and Forecast (2017-2028) 9.3.6 India Market Size and Forecast (2017-2028) 9.3.7 Southeast Asia Market Size and Forecast (2017-2028) 9.3.8 Australia Market Size and Forecast (2017-2028) 10 South America by Region, by Type, and by Application 10.1 South America Polycythemia Vera Drug Sales by Type (2017-2028) 10.2 South America Polycythemia Vera Drug Sales by Application (2017-2028) 10.3 South America Polycythemia Vera Drug Market Size by Country 10.3.1 South America Polycythemia Vera Drug Sales in Volume by Country (2017-2028) 10.3.2 South America Polycythemia Vera Drug Revenue by Country (2017-2028) 10.3.3 Brazil Market Size and Forecast (2017-2028) 10.3.4 Argentina Market Size and Forecast (2017-2028) 11 Middle East & Africa by Country, by Type, and by Application 11.1 Middle East & Africa Polycythemia Vera Drug Sales by Type (2017-2028) 11.2 Middle East & Africa Polycythemia Vera Drug Sales by Application (2017-2028) 11.3 Middle East & Africa Polycythemia Vera Drug Market Size by Country 11.3.1 Middle East & Africa Polycythemia Vera Drug Sales in Volume by Country (2017-2028) 11.3.2 Middle East & Africa Polycythemia Vera Drug Revenue by Country (2017-2028) 11.3.3 Turkey Market Size and Forecast (2017-2028) 11.3.4 Egypt Market Size and Forecast (2017-2028) 11.3.5 Saudi Arabia Market Size and Forecast (2017-2028) 11.3.6 South Africa Market Size and Forecast (2017-2028) 12 Raw Material and Industry Chain 12.1 Raw Material of Polycythemia Vera Drug and Key Manufacturers 12.2 Manufacturing Costs Percentage of Polycythemia Vera Drug 12.3 Polycythemia Vera Drug Production Process 12.4 Polycythemia Vera Drug Industrial Chain 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Polycythemia Vera Drug Typical Distributors 13.3 Polycythemia Vera Drug Typical Customers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Research Process and Data Source 15.3 Disclaimer

List of Tables Table 1. Global Polycythemia Vera Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global Polycythemia Vera Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 3. ANP Technologies, Inc. Basic Information, Manufacturing Base and Competitors Table 4. ANP Technologies, Inc. Major Business Table 5. ANP Technologies, Inc. Polycythemia Vera Drug Product and Services Table 6. ANP Technologies, Inc. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table 8. Bristol-Myers Squibb Company Major Business Table 9. Bristol-Myers Squibb Company Polycythemia Vera Drug Product and Services Table 10. Bristol-Myers Squibb Company Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 11. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors Table 12. F. Hoffmann-La Roche Ltd. Major Business Table 13. F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Product and Services Table 14. F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 15. Galena Biopharma, Inc. Basic Information, Manufacturing Base and Competitors Table 16. Galena Biopharma, Inc. Major Business Table 17. Galena Biopharma, Inc. Polycythemia Vera Drug Product and Services Table 18. Galena Biopharma, Inc. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 19. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors Table 20. Gilead Sciences, Inc. Major Business Table 21. Gilead Sciences, Inc. Polycythemia Vera Drug Product and Services Table 22. Gilead Sciences, Inc. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 23. Italfarmaco S.p.A. Basic Information, Manufacturing Base and Competitors Table 24. Italfarmaco S.p.A. Major Business Table 25. Italfarmaco S.p.A. Polycythemia Vera Drug Product and Services Table 26. Italfarmaco S.p.A. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 27. Karus Therapeutics Limited Basic Information, Manufacturing Base and Competitors Table 28. Karus Therapeutics Limited Major Business Table 29. Karus Therapeutics Limited Polycythemia Vera Drug Product and Services Table 30. Karus Therapeutics Limited Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 31. miRagen Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table 32. miRagen Therapeutics, Inc. Major Business Table 33. miRagen Therapeutics, Inc. Polycythemia Vera Drug Product and Services Table 34. miRagen Therapeutics, Inc. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 35. Nerviano Medical Sciences S.r.l. Basic Information, Manufacturing Base and Competitors Table 36. Nerviano Medical Sciences S.r.l. Major Business Table 37. Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Product and Services Table 38. Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 39. Novartis AG Basic Information, Manufacturing Base and Competitors Table 40. Novartis AG Major Business Table 41. Novartis AG Polycythemia Vera Drug Product and Services Table 42. Novartis AG Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 43. PharmaEssentia Corporation Basic Information, Manufacturing Base and Competitors Table 44. PharmaEssentia Corporation Major Business Table 45. PharmaEssentia Corporation Polycythemia Vera Drug Product and Services Table 46. PharmaEssentia Corporation Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 47. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors Table 48. Teva Pharmaceutical Industries Ltd. Major Business Table 49. Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Product and Services Table 50. Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 51. Global Polycythemia Vera Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs) Table 52. Global Polycythemia Vera Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million) Table 53. Market Position of Manufacturers in Polycythemia Vera Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021 Table 54. Global Polycythemia Vera Drug Production Capacity by Company, (K Pcs): 2020 VS 2021 Table 55. Head Office and Polycythemia Vera Drug Production Site of Key Manufacturer Table 56. Polycythemia Vera Drug New Entrant and Capacity Expansion Plans Table 57. Polycythemia Vera Drug Mergers & Acquisitions in the Past Five Years Table 58. Global Polycythemia Vera Drug Sales by Region (2017-2022) & (K Pcs) Table 59. Global Polycythemia Vera Drug Sales by Region (2023-2028) & (K Pcs) Table 60. Global Polycythemia Vera Drug Revenue by Region (2017-2022) & (USD Million) Table 61. Global Polycythemia Vera Drug Revenue by Region (2023-2028) & (USD Million) Table 62. Global Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 63. Global Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 64. Global Polycythemia Vera Drug Revenue by Type (2017-2022) & (USD Million) Table 65. Global Polycythemia Vera Drug Revenue by Type (2023-2028) & (USD Million) Table 66. Global Polycythemia Vera Drug Price by Type (2017-2022) & (USD/Pcs) Table 67. Global Polycythemia Vera Drug Price by Type (2023-2028) & (USD/Pcs) Table 68. Global Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 69. Global Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 70. Global Polycythemia Vera Drug Revenue by Application (2017-2022) & (USD Million) Table 71. Global Polycythemia Vera Drug Revenue by Application (2023-2028) & (USD Million) Table 72. Global Polycythemia Vera Drug Price by Application (2017-2022) & (USD/Pcs) Table 73. Global Polycythemia Vera Drug Price by Application (2023-2028) & (USD/Pcs) Table 74. North America Polycythemia Vera Drug Sales by Country (2017-2022) & (K Pcs) Table 75. North America Polycythemia Vera Drug Sales by Country (2023-2028) & (K Pcs) Table 76. North America Polycythemia Vera Drug Revenue by Country (2017-2022) & (USD Million) Table 77. North America Polycythemia Vera Drug Revenue by Country (2023-2028) & (USD Million) Table 78. North America Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 79. North America Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 80. North America Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 81. North America Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 82. Europe Polycythemia Vera Drug Sales by Country (2017-2022) & (K Pcs) Table 83. Europe Polycythemia Vera Drug Sales by Country (2023-2028) & (K Pcs) Table 84. Europe Polycythemia Vera Drug Revenue by Country (2017-2022) & (USD Million) Table 85. Europe Polycythemia Vera Drug Revenue by Country (2023-2028) & (USD Million) Table 86. Europe Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 87. Europe Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 88. Europe Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 89. Europe Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 90. Asia-Pacific Polycythemia Vera Drug Sales by Region (2017-2022) & (K Pcs) Table 91. Asia-Pacific Polycythemia Vera Drug Sales by Region (2023-2028) & (K Pcs) Table 92. Asia-Pacific Polycythemia Vera Drug Revenue by Region (2017-2022) & (USD Million) Table 93. Asia-Pacific Polycythemia Vera Drug Revenue by Region (2023-2028) & (USD Million) Table 94. Asia-Pacific Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 95. Asia-Pacific Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 96. Asia-Pacific Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 97. Asia-Pacific Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 98. South America Polycythemia Vera Drug Sales by Country (2017-2022) & (K Pcs) Table 99. South America Polycythemia Vera Drug Sales by Country (2023-2028) & (K Pcs) Table 100. South America Polycythemia Vera Drug Revenue by Country (2017-2022) & (USD Million) Table 101. South America Polycythemia Vera Drug Revenue by Country (2023-2028) & (USD Million) Table 102. South America Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 103. South America Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 104. South America Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 105. South America Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 106. Middle East & Africa Polycythemia Vera Drug Sales by Region (2017-2022) & (K Pcs) Table 107. Middle East & Africa Polycythemia Vera Drug Sales by Region (2023-2028) & (K Pcs) Table 108. Middle East & Africa Polycythemia Vera Drug Revenue by Region (2017-2022) & (USD Million) Table 109. Middle East & Africa Polycythemia Vera Drug Revenue by Region (2023-2028) & (USD Million) Table 110. Middle East & Africa Polycythemia Vera Drug Sales by Type (2017-2022) & (K Pcs) Table 111. Middle East & Africa Polycythemia Vera Drug Sales by Type (2023-2028) & (K Pcs) Table 112. Middle East & Africa Polycythemia Vera Drug Sales by Application (2017-2022) & (K Pcs) Table 113. Middle East & Africa Polycythemia Vera Drug Sales by Application (2023-2028) & (K Pcs) Table 114. Polycythemia Vera Drug Raw Material Table 115. Key Manufacturers of Polycythemia Vera Drug Raw Materials Table 116. Direct Channel Pros & Cons Table 117. Indirect Channel Pros & Cons Table 118. Polycythemia Vera Drug Typical Distributors Table 119. Polycythemia Vera Drug Typical Customers List of Figures Figure 1. Polycythemia Vera Drug Picture Figure 2. Global Polycythemia Vera Drug Revenue Market Share by Type in 2021 Figure 3. Dasatinib Figure 4. Idelalisib Figure 5. Givinostat Figure 6. M-009 Figure 7. Others Figure 8. Global Polycythemia Vera Drug Revenue Market Share by Application in 2021 Figure 9. Clinic Figure 10. Hospital Figure 11. Others Figure 12. Global Polycythemia Vera Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028 Figure 13. Global Polycythemia Vera Drug Revenue and Forecast (2017-2028) & (USD Million) Figure 14. Global Polycythemia Vera Drug Sales (2017-2028) & (K Pcs) Figure 15. Global Polycythemia Vera Drug Price (2017-2028) & (USD/Pcs) Figure 16. Global Polycythemia Vera Drug Production Capacity (2017-2028) & (K Pcs) Figure 17. Global Polycythemia Vera Drug Production Capacity by Geographic Region: 2022 VS 2028 Figure 18. Polycythemia Vera Drug Market Drivers Figure 19. Polycythemia Vera Drug Market Restraints Figure 20. Polycythemia Vera Drug Market Trends Figure 21. Global Polycythemia Vera Drug Sales Market Share by Manufacturer in 2021 Figure 22. Global Polycythemia Vera Drug Revenue Market Share by Manufacturer in 2021 Figure 23. Polycythemia Vera Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021 Figure 24. Top 3 Polycythemia Vera Drug Manufacturer (Revenue) Market Share in 2021 Figure 25. Top 6 Polycythemia Vera Drug Manufacturer (Revenue) Market Share in 2021 Figure 26. Global Polycythemia Vera Drug Sales Market Share by Region (2017-2028) Figure 27. Global Polycythemia Vera Drug Revenue Market Share by Region (2017-2028) Figure 28. North America Polycythemia Vera Drug Revenue (2017-2028) & (USD Million) Figure 29. Europe Polycythemia Vera Drug Revenue (2017-2028) & (USD Million) Figure 30. Asia-Pacific Polycythemia Vera Drug Revenue (2017-2028) & (USD Million) Figure 31. South America Polycythemia Vera Drug Revenue (2017-2028) & (USD Million) Figure 32. Middle East & Africa Polycythemia Vera Drug Revenue (2017-2028) & (USD Million) Figure 33. Global Polycythemia Vera Drug Sales Market Share by Type (2017-2028) Figure 34. Global Polycythemia Vera Drug Revenue Market Share by Type (2017-2028) Figure 35. Global Polycythemia Vera Drug Price by Type (2017-2028) & (USD/Pcs) Figure 36. Global Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 37. Global Polycythemia Vera Drug Revenue Market Share by Application (2017-2028) Figure 38. Global Polycythemia Vera Drug Price by Application (2017-2028) & (USD/Pcs) Figure 39. North America Polycythemia Vera Drug Sales Market Share by Type (2017-2028) Figure 40. North America Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 41. North America Polycythemia Vera Drug Sales Market Share by Country (2017-2028) Figure 42. North America Polycythemia Vera Drug Revenue Market Share by Country (2017-2028) Figure 43. United States Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 44. Canada Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 45. Mexico Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 46. Europe Polycythemia Vera Drug Sales Market Share by Type (2017-2028) Figure 47. Europe Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 48. Europe Polycythemia Vera Drug Sales Market Share by Country (2017-2028) Figure 49. Europe Polycythemia Vera Drug Revenue Market Share by Country (2017-2028) Figure 50. Germany Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. France Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. United Kingdom Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Russia Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 54. Italy Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 55. Asia-Pacific Polycythemia Vera Drug Sales Market Share by Region (2017-2028) Figure 56. Asia-Pacific Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 57. Asia-Pacific Polycythemia Vera Drug Sales Market Share by Region (2017-2028) Figure 58. Asia-Pacific Polycythemia Vera Drug Revenue Market Share by Region (2017-2028) Figure 59. China Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Japan Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Korea Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. India Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 63. Southeast Asia Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 64. Australia Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 65. South America Polycythemia Vera Drug Sales Market Share by Type (2017-2028) Figure 66. South America Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 67. South America Polycythemia Vera Drug Sales Market Share by Country (2017-2028) Figure 68. South America Polycythemia Vera Drug Revenue Market Share by Country (2017-2028) Figure 69. Brazil Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. Argentina Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. Middle East & Africa Polycythemia Vera Drug Sales Market Share by Type (2017-2028) Figure 72. Middle East & Africa Polycythemia Vera Drug Sales Market Share by Application (2017-2028) Figure 73. Middle East & Africa Polycythemia Vera Drug Sales Market Share by Region (2017-2028) Figure 74. Middle East & Africa Polycythemia Vera Drug Revenue Market Share by Region (2017-2028) Figure 75. Turkey Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Egypt Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 77. Saudi Arabia Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 78. South Africa Polycythemia Vera Drug Revenue and Growth Rate (2017-2028) & (USD Million) Figure 79. Manufacturing Cost Structure Analysis of Polycythemia Vera Drug in 2021 Figure 80. Manufacturing Process Analysis of Polycythemia Vera Drug Figure 81. Polycythemia Vera Drug Industrial Chain Figure 82. Sales Channel: Direct Channel vs Indirect Channel Figure 83. Methodology Figure 84. Research Process and Data Source

ANP Technologies, Inc. Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. Galena Biopharma, Inc. Gilead Sciences, Inc. Italfarmaco S.p.A. Karus Therapeutics Limited miRagen Therapeutics, Inc. Nerviano Medical Sciences S.r.l. Novartis AG PharmaEssentia Corporation Teva Pharmaceutical Industries Ltd.